New IV drug shows promise for inflammatory conditions
NCT ID NCT06130540
First seen Jan 29, 2026 · Last updated May 22, 2026 · Updated 19 times
Summary
This study looked at how the body handles an IV form of secukinumab, a drug that targets inflammation, in 65 adults with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). The main goals were to measure drug levels in the blood and check for side effects. Results will help determine if this treatment is safe and how it works in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Accurate Clinical Research Inc
San Antonio, Texas, 78229, United States
-
Altoona Center for Clin Res
Duncansville, Pennsylvania, 16635, United States
-
FL Medical Clinic Orlando Health
Zephyrhills, Florida, 33542, United States
-
Novartis Investigative Site
Uherské Hradiště, Uherske Hradiste, 686 01, Czechia
-
Novartis Investigative Site
Brno-Bohunice, 625 00, Czechia
-
Novartis Investigative Site
Florence, FI, 50134, Italy
-
Novartis Investigative Site
Reggio Emilia, RE, 42123, Italy
-
Novartis Investigative Site
Lisbon, 1649 035, Portugal
-
Novartis Investigative Site
Santiago de Compostela, Galicia, 15706, Spain
-
Novartis Investigative Site
Madrid, 28009, Spain
-
Novartis Investigative Site
Madrid, 28046, Spain
-
Novartis Investigative Site
Basel, 4031, Switzerland
-
Novartis Investigative Site
Bern, 3010, Switzerland
-
Novartis Investigative Site
Sankt Gallen, 9007, Switzerland
-
Overlake Internal Med Associates
Bellevue, Washington, 98004, United States
-
Rheumatology Associates of South Florida
Boca Raton, Florida, 33486, United States
-
Rheumatology Pulmonary Clinic
Beckley, West Virginia, 25801, United States
-
West Tennessee Research Institute
Jackson, Tennessee, 38305, United States
-
Willow Rheumatology Wellness
Willowbrook, Illinois, 60527, United States
Conditions
Explore the condition pages connected to this study.